Similar articles

• [Blood coagulation system and fibrinolysis in glomerulonephritis (review of the literature)].

  Panchenko VM, Gilunova NI, Kozhomkulova BZh. Panchenko VM, et al. Lab Delo. 1977;(8):451-4. Lab Delo. 1977. PMID: 72846 Russian. No abstract available.
• [The fibrinolytic therapy in renal disease (author's transl)].

  Kaburagi T, Yokoyama S, Tanaka K, Haniu T, Suzuki T, Mithunami K, Takayama S, Oguma S, Hatori T, Kishimoto T, Tomimoto K. Kaburagi T, et al. Nihon Jinzo Gakkai Shi. 1980 Jan;22(1):59-79. Nihon Jinzo Gakkai Shi. 1980. PMID: 6991744 Japanese. No abstract available.
• [Fibrin degradation products in the urine in renal diseases].

  Iversen BM, Ofstad J, Thunold S, Willassen Y. Iversen BM, et al. Tidsskr Nor Laegeforen. 1976 Jan 20;96(2):91-3. Tidsskr Nor Laegeforen. 1976. PMID: 766292 Norwegian. No abstract available.
• [Mechanism of formation and diagnostic value of fibrin fibrinogen split products in kidney allotransplantation].

  Drannik GN. Drannik GN. Urol Nefrol (Mosk). 1979 Mar-Apr;(2):62-9. Urol Nefrol (Mosk). 1979. PMID: 375530 Review. Russian. No abstract available.
• [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy].

  Veremeenko KN, Kizim AI. Veremeenko KN, et al. Vopr Med Khim. 1984 Sep-Oct;30(5):13-22. Vopr Med Khim. 1984. PMID: 6084892 Review. Russian.